["And Zebras Do Exist After All"! : Pulmonary Nocardiosis: Case Series and Overview]
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Nocardiosis is a rare disease that occurs primarily in patients with predisposing factors (immunosuppression/chronic lung disease). It is caused by aerobic, Gram-positive bacteria that are ubiquitous in soil. Cutaneous and pulmonary manifestations are most common, but disseminated forms also occur. In terms of treatment, long-term antibiotic therapy is usually necessary. The prognosis for the cutaneous or pulmonary form is generally good.
References
1.
Yang C, Kuo S, Chen F, Lee C
. Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021. J Microbiol Immunol Infect. 2022; 56(2):382-391.
DOI: 10.1016/j.jmii.2022.11.002.
View
2.
Traxler R, Bell M, Lasker B, Headd B, Shieh W, McQuiston J
. Updated Review on Species: 2006-2021. Clin Microbiol Rev. 2022; 35(4):e0002721.
PMC: 9769612.
DOI: 10.1128/cmr.00027-21.
View
3.
Lederman E, Crum N
. A case series and focused review of nocardiosis: clinical and microbiologic aspects. Medicine (Baltimore). 2004; 83(5):300-313.
DOI: 10.1097/01.md.0000141100.30871.39.
View
4.
Corti M, Villafane-Fioti M
. Nocardiosis: a review. Int J Infect Dis. 2003; 7(4):243-50.
DOI: 10.1016/s1201-9712(03)90102-0.
View
5.
Georghiou P, Blacklock Z
. Infection with Nocardia species in Queensland. A review of 102 clinical isolates. Med J Aust. 1992; 156(10):692-7.
DOI: 10.5694/j.1326-5377.1992.tb121509.x.
View